speb/financial-data huggingface dataset:
Financial ratios for CRI.PA — annual report dated 2022-12-31
Total revenue: 780744680.8510638
Gross profit: 205638297.87234044
Operating income: 51595744.680851065
Net income: 23510638.297872342
Capital expenditures: 9787234.042553192
Operating cash flow: -7872340.425531915
Depreciation & amortization: 30744680.851063833
Net tangible assets: 3936170.2127659577
Owner earnings: 44468085.10638298
Return on net tangible assets (%): 1129.7297297297296
Capex to operating income (%): 18.969072164948457
Buffett classification: The Great
Stock price: 11.659574468085108
P/E ratio: 11.984667757466065
Shares outstanding: 24166164
Book value: 297765957.44680846
P/B ratio: 0.9462706589496251
Market cap (USD): 281767188.7659575
Debt to equity: 1.2325830653804934
Current ratio: 1.3930693069306932
Quick ratio: 0.8541254125412542
Effective tax rate (%): -11.650485436893204
Interest coverage ratio: 3.0696202531645564
COGS to revenue (%): 73.66126175228233
R&D to revenue (%): 0.5722850524594632
SG&A to revenue (%): 19.484943452786485
Free cash flow (dilution-adjusted): -19361702.127659574
Buyback yield (%): 0
Inventory turnover: 3.3104715248009797
Receivables turnover: 9.060493827160494
Capitalized R&D asset: 4468085.106382979
ROCI (R&D-adjusted, %): 8.748294679399727
FCF margin (%): -2.479901893991007
Rule of 40 score: -2.479901893991007
Financial ratios for CRI.PA — annual report dated 2023-12-31
Total revenue: 724777777.7777778
Gross profit: 191777777.77777776
Operating income: 28666666.666666664
Net income: -777777.7777777778
Capital expenditures: 20333333.333333332
Operating cash flow: -20444444.444444444
Depreciation & amortization: 32333333.333333332
Net tangible assets: -4000000
Owner earnings: 11222222.222222224
Capex to operating income (%): 70.93023255813954
Buffett classification: The Good
Stock price: 10.477777777777778
Shares outstanding: 24166164
Book value: 317777777.7777778
P/B ratio: 0.7968074353846154
Market cap (USD): 253207696.13333333
Debt to equity: 1.3989510489510488
Current ratio: 1.4968051118210863
Quick ratio: 0.9508785942492012
Interest coverage ratio: 0.9961389961389961
COGS to revenue (%): 73.53978230875364
R&D to revenue (%): 0.7051969952475854
SG&A to revenue (%): 22.29035719760846
Free cash flow (dilution-adjusted): -48666666.666666664
Buyback yield (%): 0
Inventory turnover: 3.509144111192392
Receivables turnover: 8.984848484848484
Capitalized R&D asset: 8104728.132387707
ROCI (R&D-adjusted, %): 4.0474156220941
Rosenberg metric: -3.102116402116409
FCF margin (%): -6.714701824313965
Revenue growth (%): -7.168400175621868
Rule of 40 score: -13.883101999935834
Financial ratios for CRI.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -7083333.333333334
Buffett classification: The Gruesome
Stock price: 8.3125
Shares outstanding: 24166164
Book value: 328854166.66666675
P/B ratio: 0.6108520390243901
Market cap (USD): 200881238.25
Debt to equity: 1.3436807095343677
Current ratio: 1.2543778801843317
Quick ratio: 0.8202764976958525
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI.PA — annual report dated 2024-12-31
Total revenue: 450416666.6666667
Gross profit: 141875000
Operating income: 33229166.666666668
Net income: 7708333.333333334
Capital expenditures: 12083333.333333334
Operating cash flow: 45416666.66666667
Depreciation & amortization: 31250000
Net tangible assets: -7083333.333333334
Owner earnings: 26875000
Return on net tangible assets (%): -379.4117647058823
Capex to operating income (%): 36.36363636363637
Buffett classification: The Good
Stock price: 8.3125
P/E ratio: 26.060268745945944
Shares outstanding: 24166164
Book value: 328854166.66666675
P/B ratio: 0.6108520390243901
Market cap (USD): 200881238.25
Debt to equity: 1.3436807095343677
Current ratio: 1.2543778801843317
Quick ratio: 0.8202764976958525
Interest coverage ratio: 1.4052863436123346
COGS to revenue (%): 68.5013876040703
R&D to revenue (%): 0.4162812210915819
SG&A to revenue (%): 26.017576318223867
Free cash flow (dilution-adjusted): 28958333.333333336
Buyback yield (%): 0
Inventory turnover: 2.096249115357396
Receivables turnover: 4.820512820512821
Capitalized R&D asset: 6773912.529550827
ROCI (R&D-adjusted, %): 4.36231347264751
Rosenberg metric: -9.763586956521737
FCF margin (%): 6.429232192414432
Revenue growth (%): -37.85451479380653
Rule of 40 score: -31.425282601392098
Financial ratios for CRI.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -42823529.4117647
Buffett classification: The Gruesome
Stock price: 10.047058823529412
Shares outstanding: 24166164
Book value: 309882352.9411764
P/B ratio: 0.7835195161731208
Market cap (USD): 242798871.2470588
Debt to equity: 1.6017463933181475
Current ratio: 1.2986455236207466
Quick ratio: 0.8572844400396433
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRML — annual report dated 2022-06-30
Total revenue: 0
Gross profit: -7413
Operating income: -260735
Net income: -284601
Capital expenditures: 6034367
Operating cash flow: -182397
Depreciation & amortization: 7413
Net tangible assets: 30379458
Owner earnings: -6311555
Return on net tangible assets (%): -20.775732733612298
Buffett classification: The Gruesome
Stock price: 9.99
Shares outstanding: 146888753
Book value: 30379458
P/B ratio: 48.302989555310695
Market cap (USD): 1467418642.47
Debt to equity: 0
Current ratio: 0.5943085853876361
Quick ratio: 0.5943085853876361
Free cash flow (dilution-adjusted): -6216764
Buyback yield (%): 0
Retained earnings: -3789016
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8582608682485383
Rule of 40 score: 0
Financial ratios for CRML — annual report dated 2023-06-30
Total revenue: 0
Gross profit: -6757
Operating income: -439423
Net income: -5450213
Capital expenditures: 2993578
Operating cash flow: -2378789
Depreciation & amortization: 6757
Net tangible assets: 31678523
Owner earnings: -8437034
Return on net tangible assets (%): -26.633293477729374
Buffett classification: The Gruesome
Stock price: 10.69
Shares outstanding: 146888753
Book value: 31678523
P/B ratio: 49.567991840086734
Market cap (USD): 1570240769.57
Debt to equity: 0
Current ratio: 0.07090304661929785
Quick ratio: 0.07090304661929785
Free cash flow (dilution-adjusted): -5372367
Buyback yield (%): 0
Retained earnings: -9239229
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3871322220420441
Rule of 40 score: 0
Financial ratios for CRML — annual report dated 2024-06-30
Total revenue: 0
Gross profit: -26001
Operating income: -3770173
Net income: -139446204
Capital expenditures: 1068572
Operating cash flow: -15122354
Depreciation & amortization: 26001
Net tangible assets: -11065749
Owner earnings: -140488775
Buffett classification: The Gruesome
Stock price: 11.27
Shares outstanding: 146888753
Book value: -11065749
Market cap (USD): 1655436246.31
Debt to equity: -1.355534089920167
Current ratio: 0.06755942142513213
Quick ratio: 0.06755942142513213
Interest coverage ratio: -3.7420663397223453
Free cash flow (dilution-adjusted): -16799082
Buyback yield (%): 0
Retained earnings: -148685433
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -95.25334205143545
Rule of 40 score: 0
Financial ratios for CRML — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 73614406
Buffett classification: The Gruesome
Stock price: 6.79
Shares outstanding: 146888753
Book value: 73614406
P/B ratio: 13.548633848516008
Market cap (USD): 997374632.87
Debt to equity: 0.20376446425445585
Current ratio: 0.009569334372121012
Quick ratio: 0.009569334372121012
Buyback yield (%): 0
Retained earnings: -171106936
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRML — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 146888753
Market cap (USD): 525861735.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRML — annual report dated 2025-06-30
Gross profit: -11249
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.58
Shares outstanding: 146888753
Market cap (USD): 525861735.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRWC.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 115740000
Buffett classification: The Gruesome
Stock price: 0.005
Shares outstanding: 128194220
Book value: 115740000
P/B ratio: 0.005538025747364783
Market cap (USD): 640971.1
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCM.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.8346456692913387
Shares outstanding: 56205795
Market cap (USD): 46911923.385826774
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCM.TO — annual report dated 2022-12-31
Total revenue: 201326470.5882353
Gross profit: 61929411.76470588
Operating income: 21900735.294117644
Net income: 10269117.647058822
Capital expenditures: 1033088.2352941176
Operating cash flow: 18666176.470588233
Depreciation & amortization: 8220588.235294117
Net tangible assets: 2475735.2941176468
Owner earnings: 17456617.647058822
Return on net tangible assets (%): 705.1084051084051
Capex to operating income (%): 4.717139499748195
Buffett classification: The Great
Stock price: 0.8897058823529411
P/E ratio: 4.869612770299298
Shares outstanding: 56205795
Book value: 16799264.70588234
P/B ratio: 2.9767151901781435
Market cap (USD): 50006626.433823526
Debt to equity: 2.9259421368232172
Current ratio: 1.1810331179205227
Quick ratio: 0.8900099310583054
Effective tax rate (%): 29.80145765267655
Interest coverage ratio: 5.998992950654582
COGS to revenue (%): 69.23930987129478
SG&A to revenue (%): 19.882470672451824
Free cash flow (dilution-adjusted): 17288235.294117644
Buyback yield (%): 0
Retained earnings: -174880882.35294116
Inventory turnover: 9.375865479723046
Receivables turnover: 5.01059566291518
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.23031924201896
FCF margin (%): 8.587164541058566
Rule of 40 score: 8.587164541058566
Financial ratios for DCM.TO — annual report dated 2023-12-31
Total revenue: 339185606.06060606
Gross profit: 90084090.9090909
Operating income: 23990151.515151516
Net income: -12010606.06060606
Capital expenditures: 20146212.12121212
Operating cash flow: 19543181.818181816
Depreciation & amortization: 16456818.181818182
Net tangible assets: -3118939.3939393936
Owner earnings: -15700000
Capex to operating income (%): 83.97701076830771
Buffett classification: The Gruesome
Stock price: 1.6515151515151516
Shares outstanding: 56205795
Book value: 21790909.090909064
P/B ratio: 4.25979116604089
Market cap (USD): 92824722.04545455
Debt to equity: 8.939299123904892
Current ratio: 1.5536724133492372
Quick ratio: 1.306184620401438
Interest coverage ratio: 2.066901638274264
COGS to revenue (%): 73.44106315260483
R&D to revenue (%): 0.849628678318164
SG&A to revenue (%): 18.636439778882124
Free cash flow (dilution-adjusted): 15737121.212121211
Buyback yield (%): 0
Retained earnings: -195837121.2121212
Inventory turnover: 11.40131761442441
Receivables turnover: 3.7126024080400675
Capitalized R&D asset: 2881818.1818181816
ROCI (R&D-adjusted, %): 11.176464821731416
FCF margin (%): 4.639678374001898
Revenue growth (%): 68.47541461864117
Rule of 40 score: 73.11509299264307
Financial ratios for DCM.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.6592592592592592
Shares outstanding: 56205795
Market cap (USD): 93259985.77777778
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCM.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2167832167832169
Shares outstanding: 56205795
Market cap (USD): 68390268.04195805
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCM.TO — annual report dated 2024-12-31
Total revenue: 335633566.43356645
Gross profit: 90955944.05594406
Operating income: 26334965.034965035
Net income: 2496503.4965034965
Capital expenditures: 51748.25174825175
Operating cash flow: 17300699.3006993
Depreciation & amortization: 18355944.055944055
Net tangible assets: 6245454.545454546
Owner earnings: 20800699.300699297
Return on net tangible assets (%): 333.05340947262334
Capex to operating income (%): 0.196500172601503
Buffett classification: The Great
Stock price: 1.2167832167832169
P/E ratio: 27.39442109243698
Shares outstanding: 56205795
Book value: 27944055.944055974
P/B ratio: 2.4473994819819795
Market cap (USD): 68390268.04195805
Debt to equity: 6.348798798798792
Current ratio: 1.425058350300442
Quick ratio: 1.1882504841833441
Effective tax rate (%): 31.922196796338675
Interest coverage ratio: 1.752967462644882
COGS to revenue (%): 72.90022418721716
R&D to revenue (%): 1.0061338956070973
SG&A to revenue (%): 18.247297668952985
Free cash flow (dilution-adjusted): 8120979.020979021
Buyback yield (%): 0
Retained earnings: -173591608.3916084
Inventory turnover: 14.674705364257854
Receivables turnover: 4.490732337172638
Capitalized R&D asset: 5307741.258741259
ROCI (R&D-adjusted, %): 13.203075260191563
Rosenberg metric: 0.3025357922834271
FCF margin (%): 2.4195967963730007
Revenue growth (%): -1.04722593281418
Rule of 40 score: 1.3723708635588208
Financial ratios for DCM.TO — quarterly report dated 2025-03-31
Total revenue: 86486013.986014
Gross profit: 25356643.356643356
Operating income: 8168531.468531469
Net income: 3576223.7762237764
Capital expenditures: 3639860.13986014
Operating cash flow: -2919580.4195804195
Depreciation & amortization: 4830069.93006993
Net tangible assets: 1226573.4265734267
Owner earnings: 4766433.566433566
Return on net tangible assets (%): 388.5974914481185
Capex to operating income (%): 44.55954113517679
Buffett classification: The Good
Stock price: 1.202797202797203
P/E ratio: 4.725946783339852
Shares outstanding: 56205795
Book value: 22661538.461538464
P/B ratio: 2.9832119792630993
Market cap (USD): 67604173.00699301
Debt to equity: 8.467475158921188
Current ratio: 1.7096234404881159
Quick ratio: 1.4222976049540115
Effective tax rate (%): 18.489002231431304
Interest coverage ratio: 2.269036519036519
COGS to revenue (%): 70.68122094198503
R&D to revenue (%): 0.9055993531433191
SG&A to revenue (%): 18.968263594097433
Free cash flow (dilution-adjusted): -4009790.20979021
Buyback yield (%): 0
Retained earnings: -178919580.41958043
Inventory turnover: 3.463214611148528
Receivables turnover: 1.1120452461021095
Capitalized R&D asset: 783216.7832167832
ROCI (R&D-adjusted, %): 3.986689293157412
FCF margin (%): -4.636345259753385
Rule of 40 score: -4.636345259753385
Financial ratios for DCM.TO — quarterly report dated 2025-06-30
Total revenue: 83061313.86861314
Gross profit: 22268613.138686128
Operating income: 6876642.335766423
Net income: 2710948.905109489
Capital expenditures: 764233.5766423357
Operating cash flow: 7364963.503649634
Depreciation & amortization: 5216788.3211678825
Net tangible assets: 3974452.5547445253
Owner earnings: 7163503.6496350365
Return on net tangible assets (%): 180.23875114784207
Capex to operating income (%): 11.113469907653116
Buffett classification: The Great
Stock price: 1.2627737226277371
P/E ratio: 11.288890027806643
Shares outstanding: 56205795
Book value: 26122627.737226278
P/B ratio: 2.717000820107298
Market cap (USD): 70975200.98540145
Debt to equity: 7.374371297641668
Current ratio: 1.7717375458870614
Quick ratio: 1.440595305935831
Effective tax rate (%): 22.625
Interest coverage ratio: 1.8400390625
COGS to revenue (%): 73.1901506230557
R&D to revenue (%): 1.0685976413519165
SG&A to revenue (%): 17.46225635798021
Free cash flow (dilution-adjusted): 6570072.9927007295
Buyback yield (%): 0.2190546140006329
Retained earnings: -184064963.50364962
Inventory turnover: 3.333173250090047
Receivables turnover: 1.1149606607812974
Capitalized R&D asset: 1412346.4856311572
ROCI (R&D-adjusted, %): 3.2566501582804794
Rosenberg metric: -3.94275286757039
FCF margin (%): 7.909907376487337
Revenue growth (%): -3.9598311444376164
Rule of 40 score: 3.9500762320497205
Financial ratios for DCM.TO — quarterly report dated 2025-09-30
Total revenue: 75806474.8201439
Gross profit: 17720143.884892087
Operating income: 3817985.611510792
Net income: 761151.0791366907
Capital expenditures: 580575.5395683454
Operating cash flow: 7802158.273381296
Depreciation & amortization: 5031654.676258993
Net tangible assets: 6687050.359712231
Owner earnings: 5212230.215827339
Return on net tangible assets (%): 77.94513179128565
Capex to operating income (%): 15.20633126059921
Buffett classification: The Great
Stock price: 0.9352517985611511
P/E ratio: 7.458024439530629
Shares outstanding: 56205795
Book value: 28351079.136690646
P/B ratio: 1.8541294534104755
Market cap (USD): 52566570.86330935
Debt to equity: 6.615991676816891
Current ratio: 1.7647878194431037
Quick ratio: 1.4679281192679527
Effective tax rate (%): 26.065688329839272
Interest coverage ratio: 1.0548598688133572
COGS to revenue (%): 76.62449820159246
R&D to revenue (%): 1.0486756318152053
SG&A to revenue (%): 17.29033605071604
Free cash flow (dilution-adjusted): 7151079.136690648
Buyback yield (%): 0.5843908772423528
Retained earnings: -178544604.31654677
Inventory turnover: 3.7509872241579556
Receivables turnover: 1.0730462942218781
Capitalized R&D asset: 1648111.6986253783
ROCI (R&D-adjusted, %): 1.7594945458387892
Rosenberg metric: -5.124508945475194
FCF margin (%): 9.43333554773135
Revenue growth (%): -8.7343177113054
Rule of 40 score: 0.6990178364259503
Financial ratios for DCM.TO — quarterly report dated 2025-12-31
Total revenue: 78480291.97080292
Gross profit: 18456204.379562043
Operating income: 4323357.6642335765
Net income: -462773.7226277372
Capital expenditures: 645985.401459854
Operating cash flow: 6055474.452554744
Depreciation & amortization: 5089051.094890511
Net tangible assets: 5545255.474452554
Owner earnings: 3980291.970802919
Capex to operating income (%): 14.941752490292082
Buffett classification: The Great
Stock price: 1.1605839416058394
P/E ratio: 9.905253582062699
Shares outstanding: 56205795
Book value: 27310948.905109495
P/B ratio: 2.3884758940025654
Market cap (USD): 65231543.10218978
Debt to equity: 6.776138550352789
Current ratio: 1.6461563351039448
Quick ratio: 1.3863348343085178
Interest coverage ratio: 1.188879967884384
COGS to revenue (%): 76.48300749641919
R&D to revenue (%): 1.0714485016462358
SG&A to revenue (%): 16.93669897133503
Free cash flow (dilution-adjusted): 5401459.854014598
Buyback yield (%): 0.3647870233681073
Retained earnings: -182327007.29927006
Inventory turnover: 4.266967621419676
Receivables turnover: 1.1200958433170123
Capitalized R&D asset: 1666406.9211783856
ROCI (R&D-adjusted, %): 2.070532351584846
Rosenberg metric: 0.9259041516662785
FCF margin (%): 6.882568500158112
Revenue growth (%): 3.5271619700069694
Rule of 40 score: 10.409730470165082
Financial ratios for DCM.TO — annual report dated 2025-12-31
Total revenue: 328728467.15328467
Gross profit: 85170802.91970803
Operating income: 23600000
Net income: 6753284.671532846
Capital expenditures: 1799999.9999999998
Operating cash flow: 18289051.09489051
Depreciation & amortization: 20452554.744525544
Net tangible assets: 5545255.474452554
Owner earnings: 25405839.41605839
Return on net tangible assets (%): 458.15453468474396
Capex to operating income (%): 7.627118644067796
Buffett classification: The Great
Stock price: 1.1605839416058394
P/E ratio: 9.65923195525292
Shares outstanding: 56205795
Book value: 27310948.905109495
P/B ratio: 2.3884758940025654
Market cap (USD): 65231543.10218978
Debt to equity: 6.776138550352789
Current ratio: 1.6461563351039448
Quick ratio: 1.3863348343085178
Effective tax rate (%): 18.863456985003946
Interest coverage ratio: 1.5942014693555546
COGS to revenue (%): 74.09083440285283
R&D to revenue (%): 1.0198553151048722
SG&A to revenue (%): 17.71013282766155
Free cash flow (dilution-adjusted): 15041605.839416057
Buyback yield (%): 1.080933326912858
Retained earnings: -182327007.29927006
Inventory turnover: 17.31392694063927
Receivables turnover: 4.691717887279926
Capitalized R&D asset: 6566093.206064008
ROCI (R&D-adjusted, %): 11.113617013286152
Rosenberg metric: -1.71313974421568
FCF margin (%): 4.575693115254975
Revenue growth (%): -2.0573327494193108
Rule of 40 score: 2.518360365835664
Financial ratios for DEEPAKFERT.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.09653171567981
Shares outstanding: 126237825
Market cap (USD): 895850728.8309376
Buyback yield (%): 0
Retained earnings: 346766451.2725834
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEEPAKFERT.NS — annual report dated 2023-03-31
Total revenue: 1059699147.3812425
Gross profit: 111267965.89524971
Operating income: 243076735.68818516
Net income: 148706455.54202193
Capital expenditures: 147215590.74299636
Operating cash flow: 60065773.44701584
Depreciation & amortization: 29136419.00121803
Net tangible assets: 607288672.3507918
Owner earnings: 30627283.800243586
Return on net tangible assets (%): 5.043282576255953
Capex to operating income (%): 60.56342262710081
Buffett classification: The Good
Stock price: 6.4678440925700365
P/E ratio: 5.490592642458718
Shares outstanding: 126237825
Book value: 632554202.1924483
P/B ratio: 1.2907772454205153
Market cap (USD): 816486570.68514
Debt to equity: 0.7122448861699854
Current ratio: 1.5560568039440479
Quick ratio: 1.1092279788884118
Effective tax rate (%): 32.7531506124967
Interest coverage ratio: 11.454169775583997
COGS to revenue (%): 89.50004195339609
SG&A to revenue (%): 3.889022347941927
Free cash flow (dilution-adjusted): -87239951.27892815
Buyback yield (%): 0
Retained earnings: 454045066.99147385
Inventory turnover: 6.185256970370959
Receivables turnover: 5.146391959917896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.195099839605756
FCF margin (%): -8.232520663484339
Rule of 40 score: -8.232520663484339
Financial ratios for DEEPAKFERT.NS — annual report dated 2024-03-31
Total revenue: 851237558.460247
Gross profit: 128954311.06847344
Operating income: 116850941.35987528
Net income: 56069073.03033937
Capital expenditures: 99061038.4938242
Operating cash flow: 87755126.5139705
Depreciation & amortization: 40020386.13742655
Net tangible assets: 656734620.4580885
Owner earnings: -2971579.3260582834
Return on net tangible assets (%): -0.45247794672154396
Capex to operating income (%): 84.77555879394923
Buffett classification: The Gruesome
Stock price: 5.956693857965451
P/E ratio: 13.411316367108952
Shares outstanding: 126237825
Book value: 669106607.5068954
P/B ratio: 1.1238270081089705
Market cap (USD): 751960076.8204175
Debt to equity: 0.7435641470478592
Current ratio: 1.361245797088164
Quick ratio: 0.9708488981577578
Effective tax rate (%): 30.418477290314904
Interest coverage ratio: 2.4935895795480714
COGS to revenue (%): 84.85096084085725
SG&A to revenue (%): 5.633467493699347
Free cash flow (dilution-adjusted): -18347523.68389495
Buyback yield (%): 0
Retained earnings: 494149178.55858016
Inventory turnover: 5.051088524370199
Receivables turnover: 4.8100762324241915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.679968127350305
FCF margin (%): -2.155394049703668
Revenue growth (%): -19.671770939530475
Rule of 40 score: -21.82716498923414
Financial ratios for DEEPAKFERT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 670160057.3339704
Buffett classification: The Gruesome
Stock price: 12.651337792642142
Shares outstanding: 126237825
Book value: 682734113.7123746
P/B ratio: 2.339237683026147
Market cap (USD): 1597077366.2834451
Debt to equity: 0.6605789165216023
Current ratio: 1.045155743667747
Quick ratio: 0.7789669995370677
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEEPAKFERT.NS — quarterly report dated 2024-12-31
Total revenue: 300620118.8949761
Gross profit: 104874694.02028207
Operating income: 45063527.217624426
Net income: 29501107.355169598
Capital expenditures: 0
Depreciation & amortization: 11600419.629327426
Owner earnings: 41101526.984497026
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.847068422893111
P/E ratio: 14.813204969625431
Shares outstanding: 126237825
Market cap (USD): 1748023800.3322065
Effective tax rate (%): 15.858239968084042
Interest coverage ratio: 3.930059977635458
COGS to revenue (%): 65.1138804662236
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DEEPAKFERT.NS — quarterly report dated 2025-03-31
Total revenue: 311824877.2504091
Gross profit: 104954407.29483283
Operating income: 43417114.80009352
Net income: 32483048.866027586
Capital expenditures: 0
Depreciation & amortization: 12695814.823474398
Net tangible assets: 721283610.0070142
Owner earnings: 45178863.689501986
Return on net tangible assets (%): 6.263675350818334
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.933364453261758
P/E ratio: 12.565629270561
Shares outstanding: 126237825
Book value: 731098901.0989012
P/B ratio: 2.2331859561791543
Market cap (USD): 1632679798.5120785
Debt to equity: 0.6639733794704675
Current ratio: 1.1916790743182881
Quick ratio: 0.8885636902482948
Effective tax rate (%): 13.168750000000001
Interest coverage ratio: 3.6760368207463126
COGS to revenue (%): 66.34187489455827
Buyback yield (%): 0
Retained earnings: 571819032.031798
Inventory turnover: 1.6556605538922158
Receivables turnover: 1.6493528978920486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.85997295659648
Revenue growth (%): 3.727215063522583
Rule of 40 score: 3.727215063522583
Financial ratios for DEEPAKFERT.NS — annual report dated 2025-03-31
Total revenue: 1201124620.0607903
Gross profit: 421404021.51040447
Operating income: 177857142.85714284
Net income: 110436053.30839373
Capital expenditures: 130531914.89361702
Operating cash flow: 219740472.29366377
Depreciation & amortization: 47151040.448912784
Net tangible assets: 721283610.0070142
Owner earnings: 27055178.863689497
Return on net tangible assets (%): 3.750976521347324
Capex to operating income (%): 73.39143809279672
Buffett classification: The Good
Stock price: 12.933364453261758
P/E ratio: 14.783938302764266
Shares outstanding: 126237825
Book value: 731098901.0989012
P/B ratio: 2.2331859561791543
Market cap (USD): 1632679798.5120785
Debt to equity: 0.6639733794704675
Current ratio: 1.1916790743182881
Quick ratio: 0.8885636902482948
Effective tax rate (%): 20.56857452765936
Interest coverage ratio: 3.6844667247893055
COGS to revenue (%): 64.91587846321252
SG&A to revenue (%): 4.396939194621205
Free cash flow (dilution-adjusted): 86980360.06546645
Buyback yield (%): 0
Retained earnings: 571819032.031798
Inventory turnover: 6.240391092814371
Receivables turnover: 6.353176149046816
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.812284273772365
FCF margin (%): 7.24157665347533
Revenue growth (%): 41.10333926447432
Rule of 40 score: 48.34491591794965
Financial ratios for DEEPAKFERT.NS — quarterly report dated 2025-06-30
Total revenue: 311110461.0344021
Gross profit: 108584132.92768547
Operating income: 47923004.91457992
Net income: 28534987.128481165
Capital expenditures: 0
Depreciation & amortization: 12107418.6754037
Owner earnings: 40642405.803884864
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.836882752164758
P/E ratio: 27.664478923973284
Shares outstanding: 126237825
Market cap (USD): 2504164933.413293
Effective tax rate (%): 29.358940934503636
Interest coverage ratio: 4.648167063897401
COGS to revenue (%): 65.09788434414668
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.22910815272552681
Rule of 40 score: -0.22910815272552681
Financial ratios for DEEPAKFERT.NS — quarterly report dated 2025-12-31
Total revenue: 315257881.25208867
Gross profit: 90575916.2303665
Operating income: 27264119.416286066
Net income: 15761390.219449706
Capital expenditures: 0
Depreciation & amortization: 12074189.595633285
Owner earnings: 27835579.81508299
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.337752032973153
P/E ratio: 17.03008604915031
Shares outstanding: 126237825
Market cap (USD): 1809966632.0318592
Effective tax rate (%): 27.2582386509691
Interest coverage ratio: 2.5389004149377596
COGS to revenue (%): 71.26926189104864
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.333102141244932
Rule of 40 score: 1.333102141244932
Financial ratios for EBA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.97727272727273
Shares outstanding: 444000000
Market cap (USD): 27073909090.909092
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBA.DE — annual report dated 2022-12-31
Total revenue: 9795000000
Gross profit: 7115000000
Operating income: 2350000000
Net income: -1269000000
Capital expenditures: 449000000
Operating cash flow: 2254000000
Depreciation & amortization: 442000000
Net tangible assets: 891000000
Owner earnings: -1276000000
Return on net tangible assets (%): -143.20987654320987
Capex to operating income (%): 19.106382978723406
Buffett classification: The Great
Stock price: 38.56382978723404
Shares outstanding: 444000000
Book value: 5153000000
P/B ratio: 3.322790689992609
Market cap (USD): 17122340425.531914
Debt to equity: 1.8280613235008734
Current ratio: 2.175134628892531
Quick ratio: 2.175134628892531
Interest coverage ratio: 10
COGS to revenue (%): 27.36089841755998
R&D to revenue (%): 13.578356304236856
SG&A to revenue (%): 31.638591117917304
Free cash flow (dilution-adjusted): 1311000000
Buyback yield (%): 18.35613544579062
Retained earnings: 34315000000
Receivables turnover: 10.046153846153846
Capitalized R&D asset: 1330000000
ROCI (R&D-adjusted, %): 18.072849777579243
FCF margin (%): 13.3843797856049
Rule of 40 score: 13.3843797856049
Financial ratios for EBA.DE — annual report dated 2023-12-31
Total revenue: 10112000000
Gross profit: 7279000000
Operating income: 1941000000
Net income: 2767000000
Capital expenditures: 456000000
Operating cash flow: 2426000000
Depreciation & amortization: 403000000
Net tangible assets: 2129000000
Owner earnings: 2714000000
Return on net tangible assets (%): 127.47768905589479
Capex to operating income (%): 23.493044822256568
Buffett classification: The Great
Stock price: 41.64444444444444
P/E ratio: 6.682375617395493
Shares outstanding: 444000000
Book value: 6396000000
P/B ratio: 2.8908901396706272
Market cap (USD): 18490133333.333332
Debt to equity: 1.2864290181363351
Current ratio: 2.4371681415929203
Quick ratio: 2.4371681415929203
Effective tax rate (%): 25.141623954680338
Interest coverage ratio: 7.380228136882129
COGS to revenue (%): 28.01621835443038
R&D to revenue (%): 15.268987341772153
SG&A to revenue (%): 33.75197784810127
Free cash flow (dilution-adjusted): 1395000000
Buyback yield (%): 7.577014047131443
Retained earnings: 36531000000
Receivables turnover: 8.38474295190713
Capitalized R&D asset: 2435100000
ROCI (R&D-adjusted, %): 12.935690116764183
Rosenberg metric: 0.12330827067669173
FCF margin (%): 13.795490506329115
Revenue growth (%): 3.236345074017356
Rule of 40 score: 17.03183558034647
Financial ratios for EBA.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 62.81111111111111
Shares outstanding: 444000000
Market cap (USD): 27888133333.333332
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBA.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 61.3125
Shares outstanding: 444000000
Market cap (USD): 27222750000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EBA.DE — annual report dated 2024-12-31
Total revenue: 10283000000
Gross profit: 7403000000
Operating income: 2318000000
Net income: 1975000000
Capital expenditures: 458000000
Operating cash flow: 2414000000
Depreciation & amortization: 324000000
Net tangible assets: 889000000
Owner earnings: 1841000000
Return on net tangible assets (%): 207.08661417322833
Capex to operating income (%): 19.75841242450388
Buffett classification: The Great
Stock price: 61.3125
P/E ratio: 13.78367088607595
Shares outstanding: 444000000
Book value: 5158000000
P/B ratio: 5.277772392400156
Market cap (USD): 27222750000
Debt to equity: 1.5244280728964714
Current ratio: 1.2408986552968186
Quick ratio: 1.2408986552968186
Effective tax rate (%): 13.037752414398597
Interest coverage ratio: 8.94980694980695
COGS to revenue (%): 28.007390839249247
R&D to revenue (%): 14.38296217057279
SG&A to revenue (%): 31.440241174754448
Free cash flow (dilution-adjusted): 1368000000
Buyback yield (%): 11.567530833585879
Retained earnings: 37951000000
Receivables turnover: 8.677637130801688
Capitalized R&D asset: 2952380000
ROCI (R&D-adjusted, %): 14.464178038864617
Rosenberg metric: 0.08031088082901554
FCF margin (%): 13.30351064864339
Revenue growth (%): 1.6910601265822784
Rule of 40 score: 14.99457077522567
Financial ratios for EBA.DE — quarterly report dated 2025-03-31
Total revenue: 2585000000
Gross profit: 1888000000
Operating income: 611000000
Net income: 499000000
Capital expenditures: 111000000
Operating cash flow: 755000000
Depreciation & amortization: 52000000
Net tangible assets: 593000000
Owner earnings: 440000000
Return on net tangible assets (%): 74.19898819561551
Capex to operating income (%): 18.16693944353519
Buffett classification: The Great
Stock price: 66.39130434782608
P/E ratio: 14.768406377973337
Shares outstanding: 444000000
Book value: 4950000000
P/B ratio: 5.955098814229248
Market cap (USD): 29477739130.43478
Debt to equity: 1.4501010101010101
Current ratio: 1.1687074829931974
Quick ratio: 1.1687074829931974
Effective tax rate (%): 20.349761526232115
Interest coverage ratio: 10.01639344262295
COGS to revenue (%): 26.963249516441007
R&D to revenue (%): 15.203094777562862
SG&A to revenue (%): 30.831721470019342
Free cash flow (dilution-adjusted): 508000000
Buyback yield (%): 2.086320111860387
Retained earnings: 38314000000
Receivables turnover: 1.7119205298013245
Capitalized R&D asset: 393000000
ROCI (R&D-adjusted, %): 6.482512809088884
FCF margin (%): 19.65183752417795
Rule of 40 score: 19.65183752417795
Financial ratios for EBA.DE — quarterly report dated 2025-06-30
Total revenue: 2730000000
Gross profit: 1954000000
Operating income: 484000000
Net income: 368000000
Capital expenditures: 166000000
Operating cash flow: -275000000
Depreciation & amortization: 134000000
Net tangible assets: 363000000
Owner earnings: 336000000
Return on net tangible assets (%): 92.56198347107438
Capex to operating income (%): 34.29752066115703
Buffett classification: The Good
Stock price: 73.36470588235294
P/E ratio: 37.57085283940566
Shares outstanding: 444000000
Book value: 4749000000
P/B ratio: 6.859113373713352
Market cap (USD): 32573929411.7647
Debt to equity: 1.5081069698883975
Current ratio: 0.9964646464646465
Quick ratio: 0.9964646464646465
Effective tax rate (%): 22.641509433962266
Interest coverage ratio: 7.806451612903226
COGS to revenue (%): 28.424908424908423
R&D to revenue (%): 15.421245421245422
SG&A to revenue (%): 35.05494505494505
Free cash flow (dilution-adjusted): -606000000
Buyback yield (%): 1.915642390305636
Retained earnings: 38542000000
Receivables turnover: 1.6841455891425046
Capitalized R&D asset: 684310000
ROCI (R&D-adjusted, %): 4.9874160226446005
Rosenberg metric: 0.16793893129770993
FCF margin (%): -22.197802197802197
Revenue growth (%): 5.609284332688588
Rule of 40 score: -16.58851786511361
Financial ratios for EBA.DE — quarterly report dated 2025-09-30
Total revenue: 2820000000
Gross profit: 1999000000
Operating income: 576000000
Net income: 632000000
Capital expenditures: 131000000
Operating cash flow: 896000000
Depreciation & amortization: 106000000
Net tangible assets: 343000000
Owner earnings: 607000000
Return on net tangible assets (%): 176.96793002915453
Capex to operating income (%): 22.743055555555554
Buffett classification: The Great
Stock price: 90.08235294117647
P/E ratio: 26.682164580308438
Shares outstanding: 444000000
Book value: 4719000000
P/B ratio: 8.475644141954302
Market cap (USD): 39996564705.882355
Debt to equity: 1.5115490570036025
Current ratio: 0.9248842394100497
Quick ratio: 0.9248842394100497
Effective tax rate (%): -4.18848167539267
Interest coverage ratio: 9.290322580645162
COGS to revenue (%): 29.113475177304966
R&D to revenue (%): 15
SG&A to revenue (%): 31.48936170212766
Free cash flow (dilution-adjusted): 618000000
Buyback yield (%): 1.5651344174264379
Retained earnings: 39037000000
Receivables turnover: 1.8503937007874016
Capitalized R&D asset: 834760000
ROCI (R&D-adjusted, %): 4.585210403842407
Rosenberg metric: 0.10688836104513064
FCF margin (%): 21.914893617021278
Revenue growth (%): 3.296703296703297
Rule of 40 score: 25.211596913724573
Financial ratios for EBA.DE — annual report dated 2025-12-31
Total revenue: 11100000000
Gross profit: 7931000000
Operating income: 2277000000
Net income: 2031000000
Capital expenditures: 525000000
Operating cash flow: 1959000000
Depreciation & amortization: 407000000
Net tangible assets: 148000000
Owner earnings: 1913000000
Return on net tangible assets (%): 1292.5675675675675
Capex to operating income (%): 23.056653491436098
Buffett classification: The Great
Stock price: 87.27058823529413
P/E ratio: 19.078356069163263
Shares outstanding: 444000000
Book value: 4615000000
P/B ratio: 8.396130265757442
Market cap (USD): 38748141176.4706
Debt to equity: 1.5557963163596966
Current ratio: 1.096829846883761
Quick ratio: 1.096829846883761
Effective tax rate (%): 13.480710879930646
Interest coverage ratio: 9.25609756097561
COGS to revenue (%): 28.549549549549553
R&D to revenue (%): 14.792792792792792
SG&A to revenue (%): 32.36036036036036
Free cash flow (dilution-adjusted): 827000000
Buyback yield (%): 6.451922399617195
Retained earnings: 39428000000
Receivables turnover: 6.89869484151647
Capitalized R&D asset: 3142450000
ROCI (R&D-adjusted, %): 14.669152893651743
Rosenberg metric: 0.35699797160243407
FCF margin (%): 7.45045045045045
Revenue growth (%): 7.945152192939804
Rule of 40 score: 15.395602643390255
Financial ratios for EBA.DE — quarterly report dated 2025-12-31
Total revenue: 2965000000
Gross profit: 2116000000
Operating income: 601000000
Net income: 528000000
Capital expenditures: 117000000
Operating cash flow: 583000000
Depreciation & amortization: 115000000
Net tangible assets: 148000000
Owner earnings: 526000000
Return on net tangible assets (%): 355.4054054054054
Capex to operating income (%): 19.467554076539102
Buffett classification: The Great
Stock price: 87.27058823529413
P/E ratio: 19.116004527119188
Shares outstanding: 444000000
Book value: 4615000000
P/B ratio: 8.396130265757442
Market cap (USD): 38748141176.4706
Debt to equity: 1.5557963163596966
Current ratio: 1.096829846883761
Quick ratio: 1.096829846883761
Effective tax rate (%): 15.730337078651685
Interest coverage ratio: 9.852459016393443
COGS to revenue (%): 28.63406408094435
R&D to revenue (%): 14.704890387858347
SG&A to revenue (%): 32.04047217537943
Free cash flow (dilution-adjusted): 307000000
Buyback yield (%): 1.6387882895027672
Retained earnings: 39428000000
Receivables turnover: 1.8427594779366065
Capitalized R&D asset: 858340000
ROCI (R&D-adjusted, %): 4.412684044592449
Rosenberg metric: 0.2765957446808511
FCF margin (%): 10.354131534569982
Revenue growth (%): 5.141843971631205
Rule of 40 score: 15.495975506201187
Financial ratios for EDN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.3
Shares outstanding: 20589678
Market cap (USD): 109125293.39999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDN — annual report dated 2022-12-31
Total revenue: 7892858354.5377445
Gross profit: 287384789.3695222
Operating income: -1180769013.2880974
Net income: -248877579.8699463
Capital expenditures: 1216533785.694091
Operating cash flow: 1358445009.8953917
Depreciation & amortization: 737234944.8685327
Net tangible assets: 5898642917.726888
Owner earnings: -728176420.6955047
Return on net tangible assets (%): -12.344812711194189
Buffett classification: The Gruesome
Stock price: 7.99
Shares outstanding: 20589678
Book value: 5898642917.726889
P/B ratio: 0.0278897247239025
Market cap (USD): 164511527.22
Debt to equity: 0.09569343590480982
Current ratio: 0.419924706594628
Quick ratio: 0.3875332580498207
Interest coverage ratio: -0.3514063388743231
COGS to revenue (%): 96.35892630450792
SG&A to revenue (%): 15.13355284084559
Free cash flow (dilution-adjusted): 141911224.20130053
Buyback yield (%): 0
Retained earnings: -1184206955.0466497
Inventory turnover: 30.808988249307095
Receivables turnover: 4.408519830967767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.943422726184107
FCF margin (%): 1.7979699853566136
Rule of 40 score: 1.7979699853566136
Financial ratios for EDN — annual report dated 2023-12-31
Total revenue: 2485706329.3645883
Gross profit: 98299462.85799153
Operating income: -422359464.3431768
Net income: 311601772.3210971
Capital expenditures: 424675115.72068614
Operating cash flow: 253402311.9384143
Depreciation & amortization: 303430777.98955417
Net tangible assets: 1525537760.8356643
Owner earnings: 190357434.58996516
Return on net tangible assets (%): 12.478054590119783
Buffett classification: The Gruesome
Stock price: 19.37
P/E ratio: 1.279909481545005
Shares outstanding: 20589678
Book value: 1525537760.8356643
P/B ratio: 0.26143047592708024
Market cap (USD): 398822062.86
Debt to equity: 0.17299473310162874
Current ratio: 0.652790973871734
Quick ratio: 0.540864143344005
Effective tax rate (%): 51.75758458345868
Interest coverage ratio: -0.3735871075237858
COGS to revenue (%): 96.04541125004418
SG&A to revenue (%): 16.675604124873466
Free cash flow (dilution-adjusted): -171272803.78227183
Buyback yield (%): 0
Retained earnings: -22327285.328844775
Inventory turnover: 22.248099835069144
Receivables turnover: 9.446497779951835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.590592065988394
FCF margin (%): -6.890307264336156
Revenue growth (%): -68.5068929694461
Rule of 40 score: -75.39720023378226
Financial ratios for EDN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.16
Shares outstanding: 20589678
Market cap (USD): 456267264.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDN — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 13862538.555549089
Buffett classification: The Gruesome
Stock price: 42.91
Shares outstanding: 20589678
Market cap (USD): 883503082.9799999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EDN — annual report dated 2024-12-31
Total revenue: 2606944848.590661
Gross profit: 503487943.5100584
Operating income: 58013734.505034044
Net income: 347224000.4655764
Capital expenditures: 459297949.52375406
Operating cash flow: 313779122.7763875
Depreciation & amortization: 210763545.36460453
Net tangible assets: 1922952918.5823197
Owner earnings: 98689596.30642682
Return on net tangible assets (%): 5.132189943536676
Capex to operating income (%): 791.7055391148784
Buffett classification: The Gruesome
Stock price: 42.91
P/E ratio: 2.544475847854273
Shares outstanding: 20589678
Book value: 1922952918.5823193
P/B ratio: 0.4594512296387137
Market cap (USD): 883503082.9799999
Debt to equity: 0.3160856402387662
Current ratio: 0.8866602213181993
Quick ratio: 0.7492271162227468
Effective tax rate (%): -40.79494369869855
Interest coverage ratio: 0.13612962254875186
COGS to revenue (%): 80.68666685517921
SG&A to revenue (%): 13.847932885566438
Free cash flow (dilution-adjusted): -145518826.74736658
Buyback yield (%): 0
Retained earnings: 324202215.3679024
Inventory turnover: 11.006948427340971
Receivables turnover: 5.001168554713666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.573357590501404
FCF margin (%): -5.581967981640863
Revenue growth (%): 4.877427304820217
Rule of 40 score: -0.7045406768206464
Financial ratios for EDN — quarterly report dated 2025-03-31
Total revenue: 794285392.6681926
Gross profit: 163443210.38610184
Operating income: 28715620.427000865
Net income: 44669993.621252485
Capital expenditures: 78664027.61622453
Operating cash flow: 92630670.51892987
Depreciation & amortization: 49954035.49585382
Net tangible assets: 1568534013.7330682
Owner earnings: 15960001.500881776
Return on net tangible assets (%): 1.0175107049733279
Capex to operating income (%): 273.9415915327322
Buffett classification: The Gruesome
Stock price: 30.54
P/E ratio: 3.5191899256329524
Shares outstanding: 20589678
Book value: 1568534013.7330685
P/B ratio: 0.40088946788182944
Market cap (USD): 628808766.12
Debt to equity: 0.27111511135564426
Current ratio: 0.8527651714908926
Quick ratio: 0.7105150875177542
Effective tax rate (%): 0.10069648401443317
Interest coverage ratio: 0.38919826073689834
COGS to revenue (%): 79.42260906535654
SG&A to revenue (%): 16.763233105793987
Free cash flow (dilution-adjusted): 13966642.90270534
Buyback yield (%): 0
Retained earnings: 292457131.0645004
Inventory turnover: 3.901644194843471
Receivables turnover: 1.7826030206188606
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9778001795763953
FCF margin (%): 1.7583910055034604
Rule of 40 score: 1.7583910055034604
Financial ratios for EDN — quarterly report dated 2025-06-30
Total revenue: 524741625.46431607
Gross profit: 95399375.01579307
Operating income: 8222501.116043227
Net income: 78278008.47350556
Capital expenditures: 49143805.328369394
Operating cash flow: 7722176.8317849105
Depreciation & amortization: 28411512.51231859
Net tangible assets: 1571381282.4810693
Owner earnings: 57545715.657454744
Return on net tangible assets (%): 3.6621102910552206
Capex to operating income (%): 597.6746568326163
Buffett classification: The Gruesome
Stock price: 26.49
P/E ratio: 4.436188965475303
Shares outstanding: 20589678
Book value: 1571381282.481069
P/B ratio: 0.3470962625689611
Market cap (USD): 545420570.2199999
Debt to equity: 0.29727791354053495
Current ratio: 0.9934041783559738
Quick ratio: 0.8200495119419997
Effective tax rate (%): 26.173131767304042
Interest coverage ratio: 0.12935798052077122
COGS to revenue (%): 81.81974320573879
SG&A to revenue (%): 16.97349391401774
Free cash flow (dilution-adjusted): -41421628.49658448
Buyback yield (%): 0
Retained earnings: 110344246.69187942
Inventory turnover: 2.679126874418556
Receivables turnover: 1.242905537511272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.27368801752814476
FCF margin (%): -7.893718829706462
Revenue growth (%): -33.93538011550423
Rule of 40 score: -41.829098945210696
Financial ratios for EDN — quarterly report dated 2025-09-30
Total revenue: 545531328.9298311
Gross profit: 147694788.69816864
Operating income: 46305255.484127514
Net income: 29924669.185057547
Capital expenditures: 79520769.36105037
Operating cash flow: 20761260.962732233
Depreciation & amortization: 40072606.24001296
Net tangible assets: 1485681254.1881135
Owner earnings: -9523493.935979858
Return on net tangible assets (%): -0.6410186511496506
Capex to operating income (%): 171.7316285800614
Buffett classification: The Gruesome
Stock price: 15.56
P/E ratio: 2.0957008665962946
Shares outstanding: 20589678
Book value: 1485681254.1881137
P/B ratio: 0.21564207583347134
Market cap (USD): 320375389.68
Debt to equity: 0.40226609237845523
Current ratio: 1.036430054329527
Quick ratio: 0.8583066987240767
Effective tax rate (%): 2.5958150571654564
Interest coverage ratio: 1.1226901858563498
COGS to revenue (%): 72.92643321000436
SG&A to revenue (%): 19.83472747716434
Free cash flow (dilution-adjusted): -58759508.39831813
Buyback yield (%): 0
Retained earnings: 132149984.16801055
Inventory turnover: 2.565974827831869
Receivables turnover: 1.4208447927334935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.616078805782963
FCF margin (%): -10.771060300713922
Revenue growth (%): 3.9618933312407547
Rule of 40 score: -6.809166969473167